On March 24, 2023, Dins Šmits will stop working as the deputy chairman of JSC “Repharm” and its subsidiary company council, “Repharm” reports.
Content will continue after the ad
Advertising
The decision on the vacant council member position will be taken in the near future.
“Din Schmidt joined our company councils in 2016 and during this time has made a significant contribution to the company’s growth. I would especially like to highlight his contribution to the improvement and modernization of company management, the choice of strategic development directions, visibility and responsible behavior in society. As the most important point of view, the achievements of our company under his leadership a significant increase in value,” comments Andrejs Leibovičs, chairman of the board of JSC “Repharm”, wishing Šmitas success in his future career.
“Repharm” group of companies includes healthcare, pharmaceutical retail, wholesale, manufacturing and laboratory testing service providers in the Baltic region. The focus of the companies and brands represented by “Repharm” is on people and health, providing services in “Mēnes Aptiekas”, “Veselības centru viviendės” and “InMedica group” medical institutions, “Central Laboratory” and “Aprūpes birosa” branches, “Recipe Plus” wholesale , in the production of herbal medicines in the “Rīga pharmaceutical factory”, as well as in the subsidiaries of the mentioned companies.